Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV-T) in Mice with Transplanted Salivary Gland Carcinoma Cells

Overview

Journal Nutrients

Date 2020 May 20

PMID 32423101

Citations 8

Authors

Chiara Focaccetti

Monica Benvenuto

Sara Ciuffa

Sara Fazi

Manuel Scimeca

Alessandra Nardi

Martino Tony Miele

Andrea Battisti

Elena Bonanno

Andrea Modesti

Laura Masuelli

Roberto Bei

Affiliations

Soon will be listed here.

Abstract

The survival rate for head and neck cancer patients has not substantially changed in the last two decades. We previously showed that two rV-T intratumoral injections induced an efficient antitumor response and rejection of transplanted Neu (rat oncogene-encoded protein)-overexpressing salivary gland tumor cells in BALB-T mice (BALB/c mice transgenic for the rat oncogene). However, reiterated poxviral vaccinations increase neutralizing antibodies to viral proteins in humans that prevent immune response against the recombinant antigen expressed by the virus. Curcumin (CUR) is a polyphenol with antineoplastic and immunomodulatory properties. The aim of this study was to employ CUR administration to boost the anti-Neu immune response and anticancer activity induced by one rV-T intratumoral vaccination in BALB-T mice. Here, we demonstrated that the combined rV-nT+CUR treatment was more effective at reducing tumor growth and increasing mouse survival, anti-Neu humoral response, and IFN-γ/IL-2 T-cell release in vitro than the individual treatment. rV-T+CUR-treated mice showed an increased infiltration of CD4/CD8 T lymphocytes within the tumor as compared to those that received the individual treatment. Overall, CUR enhanced the antitumoral effect and immune response to Neu induced by the rV-T vaccine in mice. Thus, the combined treatment might represent a successful strategy to target ErbB2/Neu-overexpressing tumors.

Citing Articles

Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB-T Mice.

Focaccetti C, Nardozi D, Benvenuto M, Lucarini V, Angiolini V, Carrano R Int J Mol Sci. 2024; 25(11).

PMID: 38892447 PMC: 11172679. DOI: 10.3390/ijms25116259.

The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival.

Focaccetti C, Palumbo C, Benvenuto M, Carrano R, Melaiu O, Nardozi D Int J Mol Sci. 2024; 25(1).

PMID: 38203402 PMC: 10779126. DOI: 10.3390/ijms25010232.

Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics.

Paudel S, Mishra N, Agarwal R Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139779 PMC: 10746110. DOI: 10.3390/ph16121652.

Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion.

Lucarini V, Nardozi D, Angiolini V, Benvenuto M, Focaccetti C, Carrano R Biomedicines. 2023; 11(6).

PMID: 37371856 PMC: 10296425. DOI: 10.3390/biomedicines11061761.

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma.

Palumbo C, Benvenuto M, Focaccetti C, Albonici L, Cifaldi L, Rufini A Front Med (Lausanne). 2023; 10:1066021.

PMID: 36817764 PMC: 9932042. DOI: 10.3389/fmed.2023.1066021.

References

Xu B, Yu L, Zhao L . Curcumin up regulates T helper 1 cells in patients with colon cancer. Am J Transl Res. 2017; 9(4):1866-1875. PMC: 5411934. View

Singh M, Ramos I, Asafu-Adjei D, Quispe-Tintaya W, Chandra D, Jahangir A . Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1. Cancer Med. 2013; 2(4):571-82. PMC: 3799292. DOI: 10.1002/cam4.94. View

Musiani P, Allione A, Modica A, Lollini P, Giovarelli M, Cavallo F . Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest. 1996; 74(1):146-57. View

Reilly R, Machiels J, Emens L, Ercolini A, Okoye F, Lei R . The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors. Cancer Res. 2001; 61(3):880-3. View

Abdollahi E, Momtazi A, Johnston T, Sahebkar A . Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?. J Cell Physiol. 2017; 233(2):830-848. DOI: 10.1002/jcp.25778. View

Luo F, Song X, Zhang Y, Chu Y . Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity. Int Immunopharmacol. 2011; 11(9):1234-40. DOI: 10.1016/j.intimp.2011.04.002. View

Kim J, Gulley J . Poxviral vectors for cancer immunotherapy. Expert Opin Biol Ther. 2012; 12(4):463-78. PMC: 3482162. DOI: 10.1517/14712598.2012.668516. View

Mbese Z, Khwaza V, Aderibigbe B . Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers. Molecules. 2019; 24(23). PMC: 6930580. DOI: 10.3390/molecules24234386. View

Di Marco E, PIERCE J, Knicley C, Di Fiore P . Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene. Mol Cell Biol. 1990; 10(6):3247-52. PMC: 360691. DOI: 10.1128/mcb.10.6.3247-3252.1990. View

10.

Cuello M, Ettenberg S, Clark A, Keane M, Posner R, Nau M . Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res. 2001; 61(12):4892-900. View

11.

Essajee S, Kaufman H . Poxvirus vaccines for cancer and HIV therapy. Expert Opin Biol Ther. 2004; 4(4):575-88. DOI: 10.1517/14712598.4.4.575. View

12.

Montgomery R, Makary E, Schiffman K, Goodell V, Disis M . Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase. Cancer Res. 2005; 65(2):650-6. View

13.

Guo Z, Bartlett D . Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land. Cancer Gene Ther. 2014; 21(7):261-3. PMC: 4105137. DOI: 10.1038/cgt.2014.31. View

14.

Landis S, Murray T, Bolden S, Wingo P . Cancer statistics, 1999. CA Cancer J Clin. 1999; 49(1):8-31, 1. DOI: 10.3322/canjclin.49.1.8. View

15.

Gerson J, Skariah S, Denlinger C, Astsaturov I . Perspectives of HER2-targeting in gastric and esophageal cancer. Expert Opin Investig Drugs. 2017; 26(5):531-540. PMC: 5563845. DOI: 10.1080/13543784.2017.1315406. View

16.

Kaufman H, Kim-Schulze S, Manson K, DeRaffele G, Mitcham J, Seo K . Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer. J Transl Med. 2007; 5:60. PMC: 2217514. DOI: 10.1186/1479-5876-5-60. View

17.

Liao F, Liu L, Luo E, Hu J . Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma. Arch Oral Biol. 2018; 92:32-37. DOI: 10.1016/j.archoralbio.2018.04.015. View

18.

Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View

19.

Conry R, Khazaeli M, Saleh M, Allen K, Barlow D, Moore S . Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration. Clin Cancer Res. 1999; 5(9):2330-7. View

20.

Okazaki Y, Han Y, Kayahara M, Watanabe T, Arishige H, Kato N . Consumption of curcumin elevates fecal immunoglobulin A, an index of intestinal immune function, in rats fed a high-fat diet. J Nutr Sci Vitaminol (Tokyo). 2010; 56(1):68-71. DOI: 10.3177/jnsv.56.68. View